ChromaDex goes public following takeover

Phytochemical supplier ChromaDex has become a wholly owned subsidiary of Cody Resources after merging with Cody subsidiary CDI Acquisition. ChromaDex, which is based in Irvine, California, said it would benefit from being owned by a company whose shares were publicly traded.

"This merger into the public arena affords ChromaDex benefits of public ownership," said Frank Jaksch, CEO and co-founder of ChromaDex, "including the ability to enhance our visibility with customers and prospective customers, additional liquidity for existing and future equity investors, and access to potential additional avenues for capital formation to help us grow and expand to meet the needs of the sizable natural product chemistry, dietary supplement, functional food, cosmetic and pharmaceutical marketplaces with our unique skill set and value proposition."

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.